Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/933"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1903"
rdf:type	?:Evidence ?:Item
?:Evidence_assump_list_id	"167"
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:claim_assumed_valid_for_evidence_application_evidence_1903	?:desipramine_primary_total_clearance_enzyme_cyp2d6
?:content	"7.9 Drugs Metabolized by CYP2D6 Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was administered (at a dose of 60 mg twice daily) in conjunction with a single 50 mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold [see Warnings and Precautions (5.10)]."
dc:creator	"boycer"
dc:date	"05/05/2009 17:52:52"
rdfs:seeAlso	?:2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ duloxetine_inhibits_cyp2d6, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1903 }

Context graph